Chai et al. reported that the high presence of LOX1+PMNs but not LOX1-PMNs in the peripheral blood and tissue of GBM patients negatively correlated with the numbers of effector immune cells in GBM patients and was associated with an early recurrence and disease progression [141]. This evidence concerns the gene OLR1 and glioblastoma.